Lantheus Holdings, Inc.

Contributing Author

Recent Articles by Lantheus Holdings, Inc.

Sep-24	Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan LNTH GlobeNewswire
Sep-02	Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference LNTH GlobeNewswire
Aug-06	Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update LNTH GlobeNewswire
Aug-06	Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent LNTH GlobeNewswire
Jul-23	Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time LNTH GlobeNewswire
Jul-22	Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D LNTH GlobeNewswire
Jun-11	Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting LNTH GlobeNewswire
Jun-10	Lantheus to Present at the 2025 Truist Securities MedTech Conference LNTH GlobeNewswire
Jun-03	Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 LNTH GlobeNewswire
May-07	Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update LNTH GlobeNewswire
May-06	Lantheus Announces Sale of SPECT Business to SHINE Technologies LNTH GlobeNewswire
Apr-30	Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies LNTH GlobeNewswire